title: Prevention of anaphylaxis related to mast cell activation syndrome with omalizumab.
authors.forename: Matthew C
authors.initials: MC
authors.lastname: Bell
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Jackson
mesh_terms: D000707:Anaphylaxis / Q000276:immunology / Q000517:prevention & control*; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D008297:Male; D008407:Mast Cells / Q000276:immunology*; D034721:Mastocytosis, Systemic / Q000150:complications* / Q000276:immunology / Q000628:therapy; D000069444:Omalizumab; D016896:Treatment Outcome
chemical_list: D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab